Cargando…

Relapsing polychondritis patients were divided into three subgroups: patients with respiratory involvement (R subgroup), patients with auricular involvement (A subgroup), and overlapping patients with both involvements (O subgroup), and each group had distinctive clinical characteristics

Relapsing polychondritis (RP) is a multisystem disorder of cartilaginous tissues. Previously, we found that patients with respiratory involvement and patients with auricular involvement were mutually exclusive in the RP cohort, which suggests a strong inverse relationship between respiratory and aur...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimizu, Jun, Yamano, Yoshihisa, Kawahata, Kimito, Suzuki, Noboru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211876/
https://www.ncbi.nlm.nih.gov/pubmed/30334986
http://dx.doi.org/10.1097/MD.0000000000012837
_version_ 1783367423205834752
author Shimizu, Jun
Yamano, Yoshihisa
Kawahata, Kimito
Suzuki, Noboru
author_facet Shimizu, Jun
Yamano, Yoshihisa
Kawahata, Kimito
Suzuki, Noboru
author_sort Shimizu, Jun
collection PubMed
description Relapsing polychondritis (RP) is a multisystem disorder of cartilaginous tissues. Previously, we found that patients with respiratory involvement and patients with auricular involvement were mutually exclusive in the RP cohort, which suggests a strong inverse relationship between respiratory and auricular involvement. Here, we examined the clinical manifestation patterns in a subgroup of patients with respiratory involvement (R subgroup) and a subgroup of patients with auricular involvement (A subgroup) and investigated the clinical and laboratory characteristics of each subgroup. There were 47 patients (19.7%) and 118 patients (49.4%) allocated to the R and A subgroups, respectively. Saddle nose deformity and a progressive disease course were observed frequently in the R subgroup. Arthritis, conjunctivitis, and CNS involvement were observed frequently in the A subgroup. The remaining RP patients formed a third subgroup of patients that had both respiratory involvement and auricular involvement. We designated this subgroup as the O (overlap) subgroup, and 75 patients (31.4%) were allocated to the O subgroup. Disease duration in the O subgroup (5.70 ± 0.64 years) was significantly longer than that in the A subgroup (4.12 ± 0.45 years) and relatively longer than that in the R subgroup (4.80 ± 0.63 years). We found that cardiovascular involvement was more predominant in the O subgroup than in the R and A subgroups. Higher concentrations of serum matrix metalloproteinase (MMP)3 were observed in the O subgroup than in the R and A subgroups. We measured serum MMP3 concentrations in another patient cohort including 22 newly recruited RP patients. MMP3 concentrations were significantly higher in the O subgroup (n = 10) than those in the R subgroup (n = 6) and A subgroup (n = 10). RP patients in the R and A subgroups had different characteristics from each other, and the overlap of respiratory and auricular involvement was an important prognostic factor in patients with RP. Cardiovascular involvement was not observed in the R subgroup in RP patients. The current study may provide insights into the classification and treatment of RP.
format Online
Article
Text
id pubmed-6211876
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-62118762018-11-27 Relapsing polychondritis patients were divided into three subgroups: patients with respiratory involvement (R subgroup), patients with auricular involvement (A subgroup), and overlapping patients with both involvements (O subgroup), and each group had distinctive clinical characteristics Shimizu, Jun Yamano, Yoshihisa Kawahata, Kimito Suzuki, Noboru Medicine (Baltimore) Research Article Relapsing polychondritis (RP) is a multisystem disorder of cartilaginous tissues. Previously, we found that patients with respiratory involvement and patients with auricular involvement were mutually exclusive in the RP cohort, which suggests a strong inverse relationship between respiratory and auricular involvement. Here, we examined the clinical manifestation patterns in a subgroup of patients with respiratory involvement (R subgroup) and a subgroup of patients with auricular involvement (A subgroup) and investigated the clinical and laboratory characteristics of each subgroup. There were 47 patients (19.7%) and 118 patients (49.4%) allocated to the R and A subgroups, respectively. Saddle nose deformity and a progressive disease course were observed frequently in the R subgroup. Arthritis, conjunctivitis, and CNS involvement were observed frequently in the A subgroup. The remaining RP patients formed a third subgroup of patients that had both respiratory involvement and auricular involvement. We designated this subgroup as the O (overlap) subgroup, and 75 patients (31.4%) were allocated to the O subgroup. Disease duration in the O subgroup (5.70 ± 0.64 years) was significantly longer than that in the A subgroup (4.12 ± 0.45 years) and relatively longer than that in the R subgroup (4.80 ± 0.63 years). We found that cardiovascular involvement was more predominant in the O subgroup than in the R and A subgroups. Higher concentrations of serum matrix metalloproteinase (MMP)3 were observed in the O subgroup than in the R and A subgroups. We measured serum MMP3 concentrations in another patient cohort including 22 newly recruited RP patients. MMP3 concentrations were significantly higher in the O subgroup (n = 10) than those in the R subgroup (n = 6) and A subgroup (n = 10). RP patients in the R and A subgroups had different characteristics from each other, and the overlap of respiratory and auricular involvement was an important prognostic factor in patients with RP. Cardiovascular involvement was not observed in the R subgroup in RP patients. The current study may provide insights into the classification and treatment of RP. Wolters Kluwer Health 2018-10-19 /pmc/articles/PMC6211876/ /pubmed/30334986 http://dx.doi.org/10.1097/MD.0000000000012837 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle Research Article
Shimizu, Jun
Yamano, Yoshihisa
Kawahata, Kimito
Suzuki, Noboru
Relapsing polychondritis patients were divided into three subgroups: patients with respiratory involvement (R subgroup), patients with auricular involvement (A subgroup), and overlapping patients with both involvements (O subgroup), and each group had distinctive clinical characteristics
title Relapsing polychondritis patients were divided into three subgroups: patients with respiratory involvement (R subgroup), patients with auricular involvement (A subgroup), and overlapping patients with both involvements (O subgroup), and each group had distinctive clinical characteristics
title_full Relapsing polychondritis patients were divided into three subgroups: patients with respiratory involvement (R subgroup), patients with auricular involvement (A subgroup), and overlapping patients with both involvements (O subgroup), and each group had distinctive clinical characteristics
title_fullStr Relapsing polychondritis patients were divided into three subgroups: patients with respiratory involvement (R subgroup), patients with auricular involvement (A subgroup), and overlapping patients with both involvements (O subgroup), and each group had distinctive clinical characteristics
title_full_unstemmed Relapsing polychondritis patients were divided into three subgroups: patients with respiratory involvement (R subgroup), patients with auricular involvement (A subgroup), and overlapping patients with both involvements (O subgroup), and each group had distinctive clinical characteristics
title_short Relapsing polychondritis patients were divided into three subgroups: patients with respiratory involvement (R subgroup), patients with auricular involvement (A subgroup), and overlapping patients with both involvements (O subgroup), and each group had distinctive clinical characteristics
title_sort relapsing polychondritis patients were divided into three subgroups: patients with respiratory involvement (r subgroup), patients with auricular involvement (a subgroup), and overlapping patients with both involvements (o subgroup), and each group had distinctive clinical characteristics
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211876/
https://www.ncbi.nlm.nih.gov/pubmed/30334986
http://dx.doi.org/10.1097/MD.0000000000012837
work_keys_str_mv AT shimizujun relapsingpolychondritispatientsweredividedintothreesubgroupspatientswithrespiratoryinvolvementrsubgrouppatientswithauricularinvolvementasubgroupandoverlappingpatientswithbothinvolvementsosubgroupandeachgrouphaddistinctiveclinicalcharacteristics
AT yamanoyoshihisa relapsingpolychondritispatientsweredividedintothreesubgroupspatientswithrespiratoryinvolvementrsubgrouppatientswithauricularinvolvementasubgroupandoverlappingpatientswithbothinvolvementsosubgroupandeachgrouphaddistinctiveclinicalcharacteristics
AT kawahatakimito relapsingpolychondritispatientsweredividedintothreesubgroupspatientswithrespiratoryinvolvementrsubgrouppatientswithauricularinvolvementasubgroupandoverlappingpatientswithbothinvolvementsosubgroupandeachgrouphaddistinctiveclinicalcharacteristics
AT suzukinoboru relapsingpolychondritispatientsweredividedintothreesubgroupspatientswithrespiratoryinvolvementrsubgrouppatientswithauricularinvolvementasubgroupandoverlappingpatientswithbothinvolvementsosubgroupandeachgrouphaddistinctiveclinicalcharacteristics